Vasudeo Badarinarayana

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Quality Control

Escherichia Coli

Top Venues

Cancer research communications

Journal of molecular medicine (Berlin, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Esteban Terzo, Shruti A Apte, Simran Padhye, Saleh Rashed, Wesley Austin, Michael Caponegro, Anupama Reddy, Shuhao Shi, Christy Wang, Roger B Clark, David Sidransky, Vijay Modur, Vasudeo Badarinarayana
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer. Cancer research communications 3 (6) (2023)
Esteban Terzo, Shruti A Apte, Simran Padhye, Saleh Rashed, Wesley Austin, Michael Caponegro, Anupama Reddy, Shuhao Shi, Christy Wang, Roger B Clark, David Sidransky, Vijay Modur, Vasudeo Badarinarayana
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer. Cancer research communications 3 (6) (2023)
Martin R Graf, Shruti Apte, Esteban Terzo, Simran Padhye, Shuhao Shi, Megan K Cox, Roger B Clark, Vijay Modur, Vasudeo Badarinarayana
Novel read through agent: ZKN-0013 demonstrates efficacy in APC min model of familial adenomatous polyposis. Journal of molecular medicine (Berlin, Germany) (2023)
Esteban Terzo, Shruti A Apte, Simran Padhye, Saleh Rashed, Wesley Austin, Michael Caponegro, Anupama Reddy, Shuhao Shi, Christy Wang, Roger B Clark, David Sidransky, Vijay Modur, Vasudeo Badarinarayana
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer. Cancer research communications 3 (6) (2023)
Esteban Terzo, Shruti A Apte, Simran Padhye, Saleh Rashed, Wesley Austin, Michael Caponegro, Anupama Reddy, Shuhao Shi, Christy Wang, Roger B Clark, David Sidransky, Vijay Modur, Vasudeo Badarinarayana
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer. Cancer research communications 3 (6) (2023)
Esteban Terzo, Shruti A Apte, Simran Padhye, Saleh Rashed, Wesley Austin, Michael Caponegro, Anupama Reddy, Shuhao Shi, Christy Wang, Roger B Clark, David Sidransky, Vijay Modur, Vasudeo Badarinarayana
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer. Cancer research communications 3 (6) (2023)